Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_assertion description "[These data indicate that quantity and lytic efficiency of CD16(+) lymphocytes are major factors for ADCC induction by trastuzumab, and confirm that breast cancer responses to short-term trastuzumab monotherapy may depend on involvement of the ADCC mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_assertion evidence source_evidence_literature NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_assertion SIO_000772 18089830 NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_assertion wasDerivedFrom befree-2016 NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_assertion wasGeneratedBy ECO_0000203 NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.
- befree-2016 importedOn "2016-02-19" NP646032.RAeCiSfOJ861u4ObhBy99RMf5I63PnRD7MY_XJuQty1jk130_provenance.